SLC1A2 and diabetes mellitus: In addition, the β‐lactam antibiotic ceftriaxone (CEF) is a potent GLT‐1 translational activator66 and may be a promising drug for preventing and treating POCD especially in patients with diabetes, which remains to be further investigated in the future.